{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:08:58Z","timestamp":1792850938218,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Spontaneous preterm birth is an important cause of neonatal mortality and morbidity. An increasing body of evidence suggests that uteroplacental ischemia plays an important role in the etiology of spontaneous preterm birth. We aimed to study whether antiplatelet agents reduce the risk of spontaneous preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We included data from an individual participant data meta-analysis of studies that had evaluated the effect of antiplatelet agents to reduce preeclampsia (Perinatal Antiplatelet Review of International Studies Individual Participant Data).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>The meta-analysis included 31 studies that randomized women to low-dose aspirin\u2013dipyridamole or placebo\u2013no treatment as a primary preventive strategy for preeclampsia. For the current study we analyzed data from 17 trials (28,797 women) that supplied data on type of delivery (spontaneous compared with indicated birth).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>\n                      Primary endpoints were spontaneous preterm birth at less than 37 weeks, less than 34 weeks, and less than 28 weeks of gestation. We analyzed outcomes for each trial separately using \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      statistics and combined in an individual participant data meta-analysis using a binary logistic regression model. Women assigned to antiplatelet treatment compared with placebo or no treatment had a lower risk of spontaneous preterm birth at less than 37 weeks (relative risk [RR] 0.93, 95% confidence interval [CI] 0.86\u20130.996) and less than 34 weeks of gestation (RR 0.86, 95% CI 0.76\u20130.99). The RR of having a spontaneous preterm birth at less than 37 weeks of gestation was 0.83 (95% CI 0.73\u20130.95) for women who have had a previous pregnancy and 0.98 (95% CI 0.89\u20131.09) for women in their first pregnancy. The treatment effect was stable in all other prespecified subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Antiplatelet agents reduce spontaneous preterm birth in pregnant women at risk for preeclampsia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000001848","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T18:25:49Z","timestamp":1484159149000},"page":"327-336","source":"Crossref","is-referenced-by-count":82,"title":["Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth"],"prefix":"10.1097","volume":"129","author":[{"given":"Elvira O. G.","family":"van Vliet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Askie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben W. J.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn A.","family":"Oudijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-3782(98)00052-8","article-title":"Outcomes of children of extremely low birth weight in the 1990's","volume":"53","author":"Hack","year":"1999","journal-title":"Early Hum Dev"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajog.2006.05.022","article-title":"Recurrence of spontaneous versus medically indicated preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1177\/1933719113477496","article-title":"Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions","volume":"20","author":"Voltolini","year":"2013","journal-title":"Reprod Sci"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery","volume":"342","author":"Goldenberg","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9378(93)90499-9","article-title":"Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes","volume":"168","author":"Arias","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/aje\/kwp131","article-title":"Placental vascular pathology findings and pathways of preterm delivery","volume":"170","author":"Kelly","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1067\/mob.2002.127720","article-title":"Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes","volume":"187","author":"Kim","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3109\/14767050902994838","article-title":"A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study","volume":"22","author":"Chaiworapongsa","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.placenta.2009.04.007","article-title":"Placental blood flow and the risk of preterm delivery","volume":"30","author":"Misra","year":"2009","journal-title":"Placenta"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0029-7844(95)00340-1","article-title":"A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow","volume":"87","author":"Morris","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10641959709031640","article-title":"Low-dose aspirin in high risk pregnancy?","volume":"16","author":"Gallery","year":"1997","journal-title":"Hypertens Pregnancy"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"BJOG"},{"key":"R18-20230711","first-page":"238","article-title":"A prospective randomized placebo-controlled trial of low-dose aspirin for prevention on intra-uterine growth retardation","volume":"109","author":"Wang","year":"1996","journal-title":"Chin Med J"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/10641959909023076","article-title":"Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension","volume":"18","author":"Rogers","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0140-6736(91)93124-R","article-title":"Prevention of foetal growth retardation with low-dose aspirin: findings of the EPREDA trial","volume":"337","author":"Uzan","year":"1991","journal-title":"Lancet"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1471-0528.2002.01046.x","article-title":"Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches","volume":"109","author":"Vainio","year":"2002","journal-title":"BJOG"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"BJOG"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9378(89)80079-1","article-title":"Idiopathic recurrent foetal growth retardation and aspirin-dipyridamole therapy","volume":"160","author":"Uzan","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomised controlled trial using low dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","article-title":"Low-dose aspirin therapy to prevent pre-eclampsia: safety considerations","volume":"168","author":"Hauth","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1203\/01.pdr.0000182596.66175.ee","article-title":"Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants","volume":"59","author":"Kaukola","year":"2006","journal-title":"Pediatr Res"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpedi.159.11.1032","article-title":"Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants","volume":"159","author":"Polam","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"489.e1\u20137","DOI":"10.1016\/j.ajog.2012.03.024","article-title":"Placental pathology and long-term neurodevelopment of very preterm infants","volume":"206","author":"van Vliet","year":"2012","journal-title":"Am J Obst Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1542\/peds.2009-0994","article-title":"Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm","volume":"125","author":"Marret","year":"2010","journal-title":"Pediatrics"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/1414-431X20143629","article-title":"Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial","volume":"47","author":"Souza","year":"2014","journal-title":"Braz J Med Biol Res"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/humrep\/dep245","article-title":"Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy","volume":"24","author":"Lambers","year":"2009","journal-title":"Hum Reprod"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"e17175","DOI":"10.5812\/ircmj.7400","article-title":"Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow","volume":"16","author":"Talari","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/hr.2011.111","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation","volume":"34","author":"Bakhti","year":"2011","journal-title":"Hypertens Res"},{"key":"R40-20230711","first-page":"265","article-title":"Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS","volume":"10","author":"Jamal","year":"2012","journal-title":"Iran J Reprod Med"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajog.2014.09.015","article-title":"The CROWN initiative: journal editors invite researchers to develop core outcomes in women's health","volume":"211","author":"Khan","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201702000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:57:12Z","timestamp":1749880632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201702000-00013"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001848","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727200934.793536436","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.727200934.793534019","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}